Betamethasone Dipropionate Ointment, Augmented
Product Images NDC 0472-0382

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 0472-0382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Struct (Image 1)

FDA Label Image

Image (Image 2)

Image (Image 2)
Betamethasone Dipropionate Ointment, USP (Augmented) is a medication to be used topically for treatment. Each gram contains 0643 mg betamethasone dipropionate USP cqualnt .05 betamethasone), in an ointment base of propylene glycol, propylene glycol monostearate, white petrolatum, and wax. The dosage and frequency for this medication should be determined by a healthcare professional. The product should be opened carefully and is covered by a metal ampule. The strength of the medication is expressed as betamethasone and is only for topical use. It is not for ophthalmic or intravaginal use. The product code is 5 0472-0382-15 1.*
FDA Label Image

Image (Image 3)

Image (Image 3)
Betamethasone Dipropionate Ointment is a medication used topically for the treatment of various skin conditions, such as eczema, psoriasis, and dermatitis. It should not be used orally, ophthalmically, or intravaginally. The strength of the medication is indicated as "augmented" and it comes in a 15g-sized tube with a designated coding area.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.